PHILADELPHIA, Feb. 28, 2020 /PRNewswire/ -- Carisma Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that the company will present at two conferences in March, 2020.
About Carisma Therapeutics Inc.
Carisma Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. Carisma Therapeutics is headquartered in Philadelphia, PA.
For more information, please visit www.carismatx.com.
Media Contact:
Christina Khoury-Folkens
612-806-0757
[email protected]
View original content:http://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-march-scientific-and-investor-conferences-301013550.html
SOURCE Carisma Therapeutics Inc.